Real-time enrollment status for this biliary tract cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:01 PM UTC
| NCT Number | NCT06282575 |
| Recruiting Status | Recruiting |
| Condition | Biliary Tract Cancer |
| Phase | PHASE3 |
| Target Enrollment | 286 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Jazz Pharmaceuticals |
| Last Updated on CT.gov | September 14, 2026 (Sep 14, 2026) |
As of October 15, 2026: Clinical trial NCT06282575 is currently recruiting participants. This phase3 study for biliary tract cancer is actively seeking new participants at 21 locations across the United States. The study is sponsored by Jazz Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06282575 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06282575 was last updated Sep 14, 2026 (September 14, 2026). HelloStudys verifies this status automatically.